Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

SIGN UP NOW

× Close FOR COVID-19 VACCINATION Arrow Pointing Right

Michael I. Anstead, MD, FCCP

Medical Director, Center for Lung Transplant
Director, Adult Cystic Fibrosis Center
| 5.00 out of 5
15 ratings
Michael I. Anstead
best doctor logo
Request an Appointment Physician Referral

Specialties

  • Cystic Fibrosis
  • Pulmonology - Pediatric
  • Transplant - Lung
This provider offers TeleCare

  • About

    Faculty Rank

    Professor of Pediatrics

    Degree

    University of Kentucky, College of Medicine

    Residency

    University of Kentucky

    Fellowship

    University of Kentucky

    Certifications and Special Training

    American Board of Internal Medicine, Critical Care Medicine

    American Board of Internal Medicine, Pulmonary Disease

    American Board of Sleep Medicine

  • Publications

    1. Serology as a diagnostic tool for predicting initial Pseudomonas aeruginosa acquisition in children with cystic fibrosis. J Cyst Fibros. 2014 Sep;13(5):542-9. Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M.
      View Publication
    2. Pulmonary exacerbations in CF patients with early lung disease. J Cyst Fibros. 2014 Jan;13(1):74-9. Anstead M, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Goss CH, Rose L, Burns JL, Marshall B, Ratjen F.
      View Publication
    3. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. J Cyst Fibros. 2013 Mar;12(2):147-53. Anstead M, Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B.
      View Publication
    4. Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest. 2012 Nov; 142(5):1259-66. PMID: 22595153. Ratjen F, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Thompson V, Emmett P, Marshall B, Accurso F, Sagel S, Anstead M.
      View Publication
    5. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics. 2012 Feb; 129(2):e339-47. PMID: 22291119. Wells J, Rosenberg M, Hoffman G, Anstead M, Farrell PM.
      View Publication
Update/Correct This Profile.